XML 50 R32.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 24 - Concentrations | 12 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] | Note 24. Concentrations e-Commerce Operations concentrations: Customers: Amazon accounted for 32.8% and 51.6% of the Company’s revenues during the years ended December 31, 2024 and 2023, respectively. No other customer accounted for 10% or more of the Company’s revenues for either period. Suppliers: The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchases for the years ended December 31, 2024 and 2023 (in thousands):
|  | For the Years Ended December 31, |
|  | 2024 |  |  | 2023 |
|  | Amount |  |  | % of Total Purchases |  |  | Amount |  |  | % of Total Purchases |
Iridium Satellite |  | $ | 1,602 |  |  |  | 16.8 | % |  | $ | 913 |  |  |  | 10.9 | %
Garmin |  | $ | 1,242 |  |  |  | 13.0 | % |  | $ | 1,921 |  |  |  | 22.4 | %
Globalstar Europe |  | $ | 975 |  |  |  | 10.2 | % |  | $ | 958 |  |  |  | 11.2 | %
Geographic: The following table sets forth revenue as to each geographic location, for the years ended December 31, 2024 and 2023 (in thousands):
|  | Years Ended December 31, |
|  | 2024 |  |  | 2023 |
|  | Amount |  |  | % of Total |  |  | Amount |  |  | % of Total |
Europe |  | $ | 6,812 |  |  |  | 49.4 | % |  | $ | 6,687 |  |  |  | 60.9 | %
North America |  |  | 4,529 |  |  |  | 32.8 | % |  |  | 2,575 |  |  |  | 23.4 | %
Asia and Pacific |  |  | 1,720 |  |  |  | 12.5 | % |  |  | 1,510 |  |  |  | 13.8 | %
Africa |  |  | 683 |  |  |  | 5.0 | % |  |  | 143 |  |  |  | 1.3 | %
South America |  |  | 47 |  |  |  | 0.3 | % |  |  | 62 |  |  |  | 0.6 | %
|  | $ | 13,791 |  |  |  | 100.0 | % |  | $ | 10,977 |  |  |  | 100.0 | %
Healthcare Operations concentrations: Suppliers: Progressive Care had significant concentrations with one vendor. The purchases from this significant vendor were approximately 98.0% of total vendor purchases for the year ended December 31, 2024. Customers: Progressive Care’s trade receivables are primarily from prescription medications billed to various insurance providers. Ultimately, the insured is responsible for payment should the insurance company not reimburse Progressive Care. Progressive Care generated reimbursements from three significant PBMs for the year ended December 31, 2024:
|  | Year Ended December 31, 2024 |
A |  |  | 29 | %
B |  |  | 23 | %
C |  |  | 20 | %

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration